Frank X. Leonard, President, CNS Cancers US at NovoCure Ltd (NVCR), sold 3,368 shares at $76.36 ($257K) on 2023-03-01, disclosed to the SEC on 2023-03-02.
Open-market sale of $257k NVCR by President, CNS Cancers US. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $76.36 | 1,684 | $129K | 50.0% |
| 2 | $76.36 | 1,684 | $129K | 50.0% |
| Total | $76.36 avg | 3,368 | $257K | 100% |
| Filing → |
| NVCR | SELL | 2026-03-03 | $231K | — | Filing → |
| NVCR | SELL | 2025-06-04 | $1.0M | — | Filing → |
| NVCR | SELL | 2025-03-04 | $47K | — | Filing → |